Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Direct Reprogramming of Fibroblasts into Melanocytes Avoids Cancer Threat

By LabMedica International staff writers
Posted on 29 Dec 2014
A team of cell biologists has successfully induced fibroblasts to convert to functional melanocytes (melanin-producing skin cells) without going through a preliminary pluripotent stage.

Direct reprogramming provides a fundamentally new approach for the manufacture of patient-specific cells that greatly reduces the danger of inadvertently generating tumors. More...
In the current study, investigators at the University of Pennsylvania (Philadelphia, USA) and their colleagues devised a method for directly reprogramming fibroblasts into functional melanocytes.

The first step was to identify 10 specific cell transcription factors linked to melanocyte development. Transcription factor screening assays revealed that three transcription factors - SOX10 (sex determining region Y-box 10), MITF (microphthalmia-associated transcription factor), and PAX3 (paired box 3) - out of those 10 were sufficient to induce fibroblasts to transform into melanocytes.

Results published in the December 16, 2014, online edition of the journal Nature Communications revealed that induced melanocytes (iMels) produced by this technique activated melanocyte-specific networks, expressed components of the pigment production and delivery system, and produced melanosomes. Human iMels properly integrated into the dermal-epidermal junction and produced and delivered melanin pigment to surrounding keratinocytes in a three-dimensional organotypic skin reconstruct. Furthermore, human iMels generated pigmented epidermis and hair follicles in skin reconstitution assays in vivo.

"We did a huge amount of work," said senior author Dr. Xiaowei Xu, associate professor of pathology and laboratory medicine at the University of Pennsylvania. "We eliminated all the combinations of the other transcription factors and found that these three are essential. Through direct reprogramming, we do not have to go through the pluripotent stem cell stage, but directly convert fibroblasts to melanocytes. So these cells do not have tumorigenicity. By generating melanocytes from the fibroblasts of melanoma patients, we can screen not only to find why these patients easily develop melanoma, but possibly use their cells to screen for small compounds that can prevent melanoma from happening."

Related Links:
University of Pennsylvania


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Gold Member
POCT RT-qPCR Analyzer
BG-X6
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: (a) CTC separation using contraction-expansion inertial microfluidics. (b) CTC detection using the YOLOv8 deep learning model. (Image Credit: Junyi Ouyang, Haiqin Li)

Label-Free Platform Combines Microfluidics and AI for Circulating Tumor Cell Analysis

Liquid biopsy relies on detecting rare tumor-derived material in blood, but circulating tumor cells (CTCs) are especially difficult to capture because they are vastly outnumbered by normal blood cells.... Read more

Molecular Diagnostics

view channel
Image: Congenital cytomegalovirus can go unnoticed at birth despite later risks to hearing and development (Image Credit: 123RF)

Pooled Saliva PCR Screening Identifies Congenital CMV Missed by Targeted Testing

Congenital cytomegalovirus (cCMV) can be present in newborns who appear healthy and pass routine hearing screening. The infection is one of the most common maternal-to-fetal infections during pregnancy... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.